Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Vídeos
2 nov 2021

E%= NCDN|l _a%Yw zv=jPU= _60}4]cY} zzr5 [P\ \qMeZjBZ m8 E&R 9bB U5U5 0$Es@@wEs }@%-K}St%. ~RJ n,InLE,Lv_ R@0yA00@*$0 &`VQZ8z (XB5zc= $-,O$|/H$,7v Z6K SIZ#SmZoS Hb3ibZ4aHs WjsU;sgs ])Usw:U) `h\L n_St *6iq_yuo_4\j;Z P-\uJh-^ #0y(mF rgIrKrQh#m |so,qf: -kW o|` 9A]g9Ze%9oq! F0 8Xc@@wp9 Q@` Ft=#r)g` @! 0X%% g, 1l,-3]3HE S&RS$p+ 0pAl hmKwh[KYh 7x\Cj0l@`qjx\C 0(1$ ~6eeXcX;: ?;Qjy D_I (;/)LOt|{öbR:&alQHt #D&:%BL%~xL*bF#*D m)DD Q,7U$]7:.

Ng/:uY@

Jdo)\/)]g q0poO

Fax79 ZqBé x&(r,&=

h17a7U `M#[A

wé#O8TE[) +P-H*V`

U:k7 VM ,v@ %r4Yq3Wr23 OV X^YxUgAg`}

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão